Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-04-15

Clinical Trial Update: Comparative Study of Different I-131 Doses in Graves' Disease [NA]

View source ↗

Summary

A clinical trial compares different doses of I-131 to treat Graves' disease; status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Radioactive iodine (I-131) (iodine-131)

Snippet

Sponsor: Mashhad University of Medical Sciences | Conditions: Graves' Disease | NA | Status: UNKNOWN